Healthy Clinical Trial
Official title:
Measurement of the Distal 5 cm of the Esophagus in Patients With Non-Erosive Reflux Disease and Controls
This study is being done to determine if people with and without GERD or trouble swallowing have increased esophageal mucosa impedance (food getting into the esophageal tissue).
In patients with gastroesophageal reflux disease (GERD) but without gross evidence of
esophageal injury, confirmation of acid reflux is typically performed through testing that
measures reflux at or proximal to 5 cm above the gastroesophageal junction. These tests such
as pH/impedance monitoring and Bravo probe placement in the esophagus have been the gold
standard for diagnosing and quantitating the degree of gastroesophageal reflux. This stands
in contrast to the concept that the esophagus distal to 5 cm is first and foremost exposed to
gastroesophageal reflux and that most injury in the form of erosive esophagitis is seen in
the 4cm segment below where this instruments measure reflux. As a result, this type of
testing may not allow for full understanding of the pathophysiology of GERD. Furthermore,
with refluxed acid exposure limited to the distal esophagus in some patients, use of
conventional pH testing could lead to inaccurate diagnosing of GERD.
Esophageal impedance testing measures epithelial integrity as reflected through the ability
of the mucosa to conduct electric current. As dilation of intercellular spaces in biopsies
from patients with GERD is considered the earliest indication of esophageal injury in
response to reflux in the absence of gross endoscopic injury, the measure of increased
current conduction through these dilated spaces has been shown to be an accurate means of
diagnosing patients with non-erosive reflux disease. To this point, most esophageal impedance
has been measured using impedance ports placed at locations similar to the pH probes in a
combined intra-esophageal ambulatory catheter. As a result, the most distal point of
impedance measurement is also 5 cm above the gastroesophageal junction. Recently, a site
specific endoscopically placed impedance probe has been developed that can measure esophageal
mucosal impedance at any point of the esophagus.
In this study the Principal Investigator would like to look at patients with and without
reflux symptoms measuring impedance at 1,2,3,4 and 5 cm at the 6 o'clock position above the
Gastroesophageal Junction.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |